Saturday 17 October 2026
Export RBOT’s income statement to Excel — free account
Vicarious Surgical Inc.
RBOT Healthcare Medical Devices
In the quarter to March 2026, EPS grew 60.4% and free cash flow grew 47.3%, each against the same quarter a year earlier.
0.02
0.06
−75.00%
Follow RBOT
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.54 | 2.97 | 4.75 | 5.11 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.50 | 1.09 | 1.20 | 1.83 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 0.89 | 0.95 | 1.02 | |
Capex/Depreciation |
0.68 | (0.03) | (0.33) | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.87) | (1.52) | (1.78) | (2.28) | |
Cash per Share |
0.52 | 1.60 | 2.25 | 4.04 | |
Shareholders Equity per Share |
0.50 | 1.61 | 2.37 | 3.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.50 | 1.61 | 2.37 | 3.88 | |
Free Cash Flow |
(6.20) | (9.32) | (10.58) | (13.53) | |
Working Capital |
1.81 | 7.68 | 11.90 | 20.97 | |
Capital Expenditures |
0.12 | (0.01) | (0.12) | 0.00 | |
Net Current Asset Value |
(3.86) | 1.84 | (0.18) | 8.24 | |
| Other line items | |||||
Quick Ratio |
1.10 | 2.51 | 4.22 | 4.70 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.89) | (1.52) | (1.76) | (2.28) | |
Capex per Share |
0.02 | 0.00 | (0.02) | 0.00 | |
Average Payables |
1.03 | 1.03 | 1.67 | 1.04 | |
Average Assets |
33.82 | 43.65 | 54.98 | 67.12 | |
Average Common Equity |
18.82 | 28.27 | 35.99 | 47.46 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates